Survivor Story
Lourdes Monje was diagnosed with metastatic breast cancer at just 25 years of age and must confront the many unique challenges as a young adult diagnosed with a terminal illness.
Read Lourdes' Story
Lourdes Monje was diagnosed with metastatic breast cancer at just 25 years of age and must confront the many unique challenges as a young adult diagnosed with a terminal illness.
Read Lourdes' Story
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreWhat is Cancer Precision Medicine? Research has powered an explosion in our understanding of the biology of cancer genomics and is leading to tailored treatments for patients.
Read the ReportMore than 310,000 women in the United States are expected to be diagnosed with breast cancer this year. Learn more during Breast Cancer Awareness Month.
Learn MoreAACR grantee and NextGen Star Chemtai Mungo, MD, MPH, is developing an innovative self-treatment strategy for cervical precancer that could save lives in underserved areas.
Read AACR StoriesThe Week in Cancer News: A roundup of significant cancer research news from the past week, selected by the staff of Cancer Today magazine.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSubmit an abstract for the AACR Annual Meeting 2025 (April 25-30, Chicago).
Deadline: November 26
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
